Zacks Investment Research on MSN15h
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome DrugShares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR ...
Western Midstream Partners L.P. 0.39% $15.77B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback